Role(s) in Healthcare Innovation:

Concerned Citizen

Ari Afilalo, Bachelor's degree in Political Science and Government from

Law Professor

United States

About Me

Ari Afilalo is a specialist in international trade law, business transactions and contracts. His scholarly interests include the treatment of intellectual property in free trade areas, the law governing the elimination of non-tariff barriers to trade, the European Union's system of judicial remedies and the international rules for the protection of cross-border investment. Professor Afilalo holds a J.D. magna cum laude from Boston University School of Law and an LL.M.from Harvard Law School (where he concentrated in international law). He served as a law clerk to Chief Justice Paul J. Liacos of the Supreme Judicial Court of Massachusetts. He practiced law for several years in New York City, focusing on cross-border commercial and financial transactions between Europe and the United States

Interested in solutions for:

For myself and those I love

I am looking for healthcare innovations:

You have not backed any projects. Lets change that!
Discover Projects

No project created yet. Lets change that!
Discover Projects

No comments on any project yet. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No project reviewed yet. Lets change that!
Discover Projects

Important Disclosure: MedStartr.com is a website owned and operated by MedStartr, Inc., which is not a broker-dealer, funding portal or investment advisor; and neither the website nor MedStartr, Inc. participate in the offer or sale of securities. All securities related activity is conducted through Young America Capital, LLC, a registered broker-dealer and member of FINRA/SIPC. No communication, through this website, email or in any other medium, should be construed as a recommendation for any securities offering.